Key facts
- This page summarizes Julia Aijun Wang's Form 4 filing for BeiGene, Ltd. (ONC).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 Jun 2024, 16:54.
Julia Aijun Wang - 05 Jun 2024 Form 4 Insider Report for BeiGene, Ltd. (ONC)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ONC
- Reported as of
- 05 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Jun 2024, 16:54:31 UTC
- Prior SEC filing
- 04 Mar 2024
- Next SEC filing
- 20 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Qing Nian, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Julia Aijun Wang filed Form 4 for BeiGene, Ltd. (ONC) on 07 Jun 2024.
Change
- Previous filing in this sequence was filed on 04 Mar 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BGNE
transaction
Ordinary Shares
Award
- Transaction value
- $0
- Shares
- +136,240
- Change %
- +43%
- Price
- $0.000000
- Shares after
- 456,326
- Date
- 05 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BGNE
transaction
Derivative
Share Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +256,659
- Change %
- Price
- $0.000000
- Shares after
- 256,659
- Date
- 05 Jun 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 256,659
- Exercise price
- $12.23
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
Footnote F2
The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
Footnote F3
These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.